Hypertension-related disease in African Americans

References

• American Heart Association. 2000 heart and stroke statistical update. Dallas: American Heart Association, 2001
   Google Scholar
• Sowers JR, Epstein M, Frohlich E. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37(4): 1053–9
   PubMed Web of Science ®Google Scholar
• US Census Bureau. Profile of general demographic characteristics: 2000 census of population and housing. Washington, DC: US Census Bureau, 2000
   Google Scholar
• Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345(7): 479–86
   PubMed Web of Science ®Google Scholar
• Geronimus AT, Andersen HF, Bound J. Differences in hypertension prevalence among US black and white women of childbearing age. Public Health Rep 1991; 106(4): 393–9
   PubMed Web of Science ®Google Scholar
• Lackland DT, Egan BM, Fan ZJ, et al. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich) 2001; 3(1): 29–31
   Google Scholar
• Berenson GS, Voors AW, Webber LS, et al. Racial differences of parameters associated with blood pressure levels in children—the Bogalusa Heart Study. Metabolism 1979; 28(12): 1218–28
   PubMedGoogle Scholar
• Young-Hyman D, Schlundt DG, Herman L, et al. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 2001; 24(8): 1359–64
   Google Scholar
• Apedo MT, Sowers JR, Banerji MA. Cardiovascular disease in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15(Suppl 1): 519–23
   Google Scholar
• McFarlane SI, Banerji MA, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001; 86(2): 713–8
   PubMed Web of Science ®Google Scholar
• Rahman M, Douglas JG, Wright JT Jr. Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am 1997; 26(1): 125–44
   Google Scholar
• Cooper R, Rotimi C. Hypertension in blacks. Am J Hypertens 1997; 10 (7 Pt 1): 804–12
   Google Scholar
• Fang J, Madhavan S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med 1996; 335(21): 1545–51
   PubMed Web of Science ®Google Scholar
• Chapman JN, Mayet J, Chang CL, et al. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens 1999; 12(5): 437–42
   Web of Science ®Google Scholar
• Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000; 283(17): 2253–9
   Google Scholar
• Gillum RF, Mussolino ME, Madans JH. Coronary heart disease risk factors and attributable risks in African-American women and men: NHANESI epidemiologic follow-up study. Am J Public Health 1998; 88(6): 913–7
   Google Scholar
• Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare from the Stroke Council of the American Heart Association. Circulation 2001; 103(1): 163–82
   PubMed Web of Science ®Google Scholar
• Becker LB, Han BH, Meyer PM, et al. Racial differences in the incidence of cardiac arrest and subsequent survival: the CPR Chicago Project. N Engl J Med 1993; 329(9): 600–6
   PubMed Web of Science ®Google Scholar
• Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998; 158(6): 617–21
   PubMedGoogle Scholar
• Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273(20): 1592–7
   PubMed Web of Science ®Google Scholar
• Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA 1997; 277(16): 1293–8
   PubMed Web of Science ®Google Scholar
• US Renal Data System. USRDS 2001 annual data report: atlas of endstage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
   Google Scholar
• Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001; 345(2): 99–106
   PubMed Web of Science ®Google Scholar
• He J, Klag MJ, Appel LJ, et al. Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites. Hypertension 1998; 31(5): 1130–5
   Google Scholar
• Exner DV, Dries DL, Domanski MJ, et al. Lesser response to angiotensin-converting enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344(18): 1351–7
   PubMed Web of Science ®Google Scholar
• Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with Carvedilol in patients with chronic heart failure. N Engl J Med 2001; 344(18): 1358–65
   Google Scholar
• Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001; 161(7): 965–71
   PubMedGoogle Scholar
• Weir MR, Gray JM, Paster RP, et al. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension 1995; 26(1): 124–30
   Google Scholar
• Bolen JC, Rhodes L, Powell-Griner EE, et al. State-specific prevalence of selected health behaviors, by race and ethnicity. Behavioral Risk Factor Surveillance System, 1997. Morb Mortal Wkly Rep CDC Surveill Summ 2000; 49(2): 1–60
   Google Scholar